Overview
Decompensation is an urgent clinical reality and a leading cause of hospitalization in patients with cirrhosis. Join us on Nov. 4 to address the importance of preventing decompensation during our Gastro Bites webinar.
Learning objectives
- Discuss the key drivers of liver disease progression, including gut dysbiosis and the gut–liver–brain axis
- Describe the burden of cirrhosis, from compensated to decompensated stages, with a focus on hepatic encephalopathy as one of the first complications of decompensation
- Identify emerging strategies to prevent decompensation, including the change from a treatment paradigm to one of prevention
- Released date:
- Oct 02, 2025
- Expiration date:
- Nov 04, 2026
Pricing
Supporter acknowldegement
This session is sponsored by Salix Pharmaceuticals, Inc.Agenda
All times are Eastern.
Session Heading 1: Lorem Ipsum Dolor sit Amet
10:00 a.m. - 5:00 p.m.
Session Sub-title 1
Person, PhD
10:00 - 11:00 a.m.
Session Sub-title 2
Person, PhD
11:00 - 12:00 midday
Session Sub-title 3
Person, PhD
12:00 - 1:00 p.m.
Session Heading 2: Lorem Ipsum Dolor sit Amet
10:00 a.m. - 5:00 p.m.
Session Sub-title 1
Person, PhD
10:00 - 11:00 a.m.
Session Sub-title 2
Person, PhD
11:00 - 12:00 midday
Session Sub-title 3
Person, PhD
12:00 - 1:00 p.m.
Course contents
Video | Management of Hepatic Encephalopathy in Patients with Decompensated Cirrhosis: Course Media
42 mins
Evaluation
Course Faculty
Speaker
Apurva Modi, MD, MS, MHSc
Transplant Hepatology
Baylor Scott & White
Arun Jesudian, MD
Professor of Clinical Medicine
Director of Liver Quality Director of Inpatient Liver Services
Kimberly Brown, MD
Chief of the Division of Gastroenterology and Hepatology
Associate Medical Director of Henry Ford Hospital Transplant